Literature DB >> 21611669

Effect of ZnO#ZnS QDs heterojunctures on the stilbenes-plasma proteins interactions.

Jianbo Xiao1, Feijiu Wang, Jie Liu, Litong Wang, Guoyin Kai, Xibin Yu.   

Abstract

Zero-dimensional nanostructures such as ZnO#ZnS QDs heterojunctures (QDHJs) are green nanoparticles and have gained a tremendous amount of attention. However, very little information is available on the effects of these heterojunctures on the transportation of drugs in blood. Herein, stilbenes were studied for their affinities for common bovine plasma proteins (CBPP) in the presence and absence of QDHJs with different diameters. The affinities of QDHJs for CBPP improved with increasing QDHJs size. QDHJs improved the affinities of resveratrol and polydatin for CBPP by 14.74% to 22.36% and 12.56% to 21.34% depending on the size of QDHJs. The number of binding sites (n) between resveratrol and polydatin for CBPP in the presence of QDHJs were 1.04 ± 0.03 and 1.06 ± 0.04, which were obviously higher than those in the absence of QDHJs (n = 0.89 and 0.92). QDHJs in blood will decrease the free concentration of stilbenes and weaken their pharmacological effects.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21611669     DOI: 10.1039/c1mb05087g

Source DB:  PubMed          Journal:  Mol Biosyst        ISSN: 1742-2051


  3 in total

1.  The interaction of dietary flavonoids with xanthine oxidase in vitro: molecular property-binding affinity relationship aspects.

Authors:  Mengmeng Yuan; Yi Liu; Aiping Xiao; Juan Leng; Liping Liao; Lei Ma; Liangliang Liu
Journal:  RSC Adv       Date:  2019-04-08       Impact factor: 4.036

Review 2.  Biokinetics of zinc oxide nanoparticles: toxicokinetics, biological fates, and protein interaction.

Authors:  Soo-Jin Choi; Jin-Ho Choy
Journal:  Int J Nanomedicine       Date:  2014-12-15

Review 3.  Polydatin: Pharmacological Mechanisms, Therapeutic Targets, Biological Activities, and Health Benefits.

Authors:  Ahmad Karami; Sajad Fakhri; Leila Kooshki; Haroon Khan
Journal:  Molecules       Date:  2022-10-01       Impact factor: 4.927

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.